Pages

Friday, January 24, 2014

Miltenyi Biotec, Inc. Receives FDA Approval For Clinimacs CD34 ...

Miltenyi Biotec Receives FDA Approval for CliniMACSA CD34 Reagent System for Prevention of Graft-Versus-Host Disease in the Treatment of Acute Myeloid Leukemia CAMBRIDGE, Mass.

http://ift.tt/1hrzuHb

No comments:

Post a Comment